Harm Reduction

Harm reduction is a set of practical strategies and a guiding philosophy aimed at reducing the harms associated with drug use — overdose, infection, injury, and the social damage of criminalization and stigma. Crucially, it does not require that a person stop using, or even want to stop, in order to receive help.

This can sound, at first, like giving up on people. It is the opposite. Harm reduction accepts that people use drugs for reasons, that change is usually gradual, and that the priority in the meantime is keeping people alive and healthy. It refuses the all-or-nothing bargain — “get clean or get nothing” — that has cost so many lives.

• Pragmatism over idealism. Meet the world as it is; reduce harm now rather than waiting for a perfect outcome.
• Dignity and autonomy. People who use drugs are treated as capable of making decisions about their own lives.
• Any positive change counts. Progress is measured in steps, not only in abstinence.
• Low-barrier access. Remove the hoops — no waitlists, no sobriety requirements, no judgment — that keep people away from help.
• Nothing about us without us. People with lived experience help design and deliver services.

• Naloxone (Narcan). A safe medication that rapidly reverses opioid overdose. Widespread distribution to people who use drugs and their networks saves lives; it is available in NH pharmacies without a prescription.
• Fentanyl and xylazine test strips. Let people check a supply for contaminants that dramatically raise overdose risk, so they can use more cautiously or not at all.
• Syringe services programs (SSPs). Provide sterile equipment and safe disposal, preventing HIV and hepatitis C — and, just as importantly, serving as a trusted door into testing, wound care, and treatment.
• Never use alone. Encouragement and tools (including overdose-response hotlines) so someone is present or reachable if an overdose occurs.
• Low-barrier treatment. Easy, fast access to medications for opioid use disorder (buprenorphine, methadone) when a person is ready.

• “It enables drug use.” Research consistently finds that harm-reduction services do not increase drug use. Syringe programs, for instance, are associated with people being more likely to enter treatment, not less.
• “It gives up on recovery.” Harm reduction and treatment are complementary. Staying alive and connected is what makes future recovery possible; a dead patient never recovers.
• “Naloxone encourages riskier use.” The evidence does not support this. Expanding naloxone access reduces overdose deaths.

The core harm-reduction practices are among the better-evidenced interventions in public health:

• Naloxone distribution reduces opioid overdose mortality at the community level.
• Syringe services programs reduce HIV and hepatitis C transmission by about 50% and increase entry into treatment, endorsed by the CDC and WHO.
• Medications for opioid use disorder (methadone, buprenorphine) — themselves a harm-reduction approach — roughly halve mortality.
• Drug-checking changes behavior, helping people avoid or reduce exposure to unexpectedly potent supplies.

The harm-reduction mindset extends past drugs. In mental health more broadly, it means meeting people where they are rather than withholding help until they meet our conditions — for example, not requiring sobriety before offering housing (see Housing & Mental Health), or working collaboratively with someone on managing self-harm rather than demanding it stop immediately. At its heart, harm reduction is a stance of radical pragmatism and respect.

New Hampshire's Doorway system offers a front door to substance-use assessment, treatment, and recovery support — call 211. Naloxone is available at pharmacies statewide, and harm-reduction organizations distribute supplies and connect people to care. Meridian maintains a directory to help you find them.